Literature DB >> 17239631

FcgammaRIII-dependent inhibition of interferon-gamma responses mediates suppressive effects of intravenous immune globulin.

Kyung-Hyun Park-Min1, Natalya V Serbina, Wentian Yang, Xiaojing Ma, Gerald Krystal, Benjamin G Neel, Stephen L Nutt, Xiaoyu Hu, Lionel B Ivashkiv.   

Abstract

Intravenous immune globulin (IVIG) suppresses autoantibody-mediated inflammation by inducing and activating the inhibitory Fc receptor FcgammaRIIb and downstream negative signaling pathways. We investigated the effects of IVIG on cellular responses to interferon-gamma (IFN-gamma), a potent macrophage activator that exacerbates inflammation. Our study showed that IVIG blocked IFN-gamma signaling and IFN-gamma-induced gene expression and suppressed IFN-gamma function in vivo during immune responses to Listeria monocytogenes and in an IFN-gamma-enhanced model of immune thrombocytopenic purpura. The mechanism of inhibition of IFN-gamma signaling was suppression of expression of the IFNGR2 subunit of the IFN-gamma receptor. The inhibitory effect of IVIG was mediated at least in part by soluble immune complexes and was dependent on FcgammaRIII but independent of FcgammaRIIb. These results reveal an unexpected inhibitory role for the activating FcgammaRIII in mediating suppression of IFN-gamma signaling and suggest that inhibition of macrophage responses to IFN-gamma contributes to the anti-inflammatory properties of IVIG.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17239631     DOI: 10.1016/j.immuni.2006.11.010

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  49 in total

Review 1.  Adoptive-transfer effects of intravenous immunoglobulin in autoimmunity.

Authors:  Alan H Lazarus
Journal:  J Clin Immunol       Date:  2010-05       Impact factor: 8.317

Review 2.  Intravenous immunoglobulin: an update on the clinical use and mechanisms of action.

Authors:  Vir-Singh Negi; Sriramulu Elluru; Sophie Sibéril; Stéphanie Graff-Dubois; Luc Mouthon; Michel D Kazatchkine; Sébastien Lacroix-Desmazes; Jagadeesh Bayry; Srini V Kaveri
Journal:  J Clin Immunol       Date:  2007-03-11       Impact factor: 8.317

Review 3.  Neuroprotection in stroke by complement inhibition and immunoglobulin therapy.

Authors:  T V Arumugam; T M Woodruff; J D Lathia; P K Selvaraj; M P Mattson; S M Taylor
Journal:  Neuroscience       Date:  2008-07-12       Impact factor: 3.590

4.  Staphylococcus aureus infection after splenectomy and splenic autotransplantation in BALB/c mice.

Authors:  F M Teixeira; B F Fernandes; A B Rezende; R R P Machado; C C S Alves; S M Perobelli; S I Nunes; R E Farias; M F Rodrigues; A P Ferreira; S C Oliveira; H C Teixeira
Journal:  Clin Exp Immunol       Date:  2008-09-08       Impact factor: 4.330

5.  Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc.

Authors:  Robert M Anthony; Falk Nimmerjahn; David J Ashline; Vernon N Reinhold; James C Paulson; Jeffrey V Ravetch
Journal:  Science       Date:  2008-04-18       Impact factor: 47.728

Review 6.  Chapter 4: Multitasking by exploitation of intracellular transport functions the many faces of FcRn.

Authors:  E Sally Ward; Raimund J Ober
Journal:  Adv Immunol       Date:  2009       Impact factor: 3.543

Review 7.  The role of B cells and humoral immunity in Mycobacterium tuberculosis infection.

Authors:  John Chan; Simren Mehta; Sushma Bharrhan; Yong Chen; Jacqueline M Achkar; Arturo Casadevall; JoAnne Flynn
Journal:  Semin Immunol       Date:  2014-10-28       Impact factor: 11.130

Review 8.  Cross-regulation of signaling by ITAM-associated receptors.

Authors:  Lionel B Ivashkiv
Journal:  Nat Immunol       Date:  2009-03-19       Impact factor: 25.606

9.  Activation of the JAK/STAT-1 signaling pathway by IFN-gamma can down-regulate functional expression of the MHC class I-related neonatal Fc receptor for IgG.

Authors:  Xindong Liu; Lilin Ye; Yu Bai; Habi Mojidi; Neil E Simister; Xiaoping Zhu
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

10.  Association of CCR2-CCR5 haplotypes and CCL3L1 copy number with Kawasaki Disease, coronary artery lesions, and IVIG responses in Japanese children.

Authors:  Manju Mamtani; Tomoyo Matsubara; Chisato Shimizu; Susumu Furukawa; Teiji Akagi; Yoshihiro Onouchi; Akira Hata; Akihiro Fujino; Weijing He; Sunil K Ahuja; Jane C Burns
Journal:  PLoS One       Date:  2010-07-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.